Opticlick


Combined with:

Apidra
Lantus

Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 77.4%
Type 1 Diabetes Mellitus 11.9%
Diabetes Mellitus 5.5%
Product Used For Unknown Indication 2.6%
Blood Pressure 1.3%
Drug Use For Unknown Indication 0.9%
Bone Disorder 0.4%
Product Quality Issue 37.8%
Device Malfunction 12.6%
Hypoglycaemia 10.5%
Wrong Drug Administered 6.3%
Blood Glucose Increased 4.2%
Visual Impairment 4.2%
Visual Acuity Reduced 3.5%
Cerebrovascular Accident 2.1%
Sepsis 2.1%
Surgery 2.1%
Uterine Cancer 2.1%
Blood Glucose Decreased 1.4%
Cataract 1.4%
Cataract Operation 1.4%
Concussion 1.4%
Dizziness 1.4%
Injection Site Pain 1.4%
Overdose 1.4%
Staphylococcal Infection 1.4%
Tremor 1.4%
Secondary
Type 2 Diabetes Mellitus 77.1%
Diabetes Mellitus 7.1%
Type 1 Diabetes Mellitus 6.2%
Insulin-requiring Type 2 Diabetes Mellitus 3.6%
Blood Pressure 1.2%
Hypertension 1.0%
Drug Use For Unknown Indication 0.7%
Asthma 0.5%
Thyroid Disorder 0.4%
Device Therapy 0.3%
Chronic Obstructive Pulmonary Disease 0.3%
Diabetes Mellitus Non-insulin-dependent 0.3%
Insomnia 0.3%
Dementia 0.2%
Depression 0.2%
Type I Diabetes Mellitus 0.2%
Anxiety 0.1%
Arthritis 0.1%
Atrial Fibrillation 0.1%
Back Pain 0.1%
Visual Impairment 13.7%
Visual Acuity Reduced 9.2%
Myocardial Infarction 6.6%
Pneumonia 6.4%
Macular Degeneration 5.9%
Vision Blurred 5.7%
Device Malfunction 5.2%
Cerebrovascular Accident 5.0%
Blood Glucose Increased 4.5%
Fall 4.3%
Hypoglycaemia 4.3%
Glaucoma 4.0%
Cataract 3.8%
Death 3.8%
Product Quality Issue 3.5%
Weight Decreased 3.3%
Cardiac Failure Congestive 2.8%
Renal Failure 2.8%
Blindness 2.6%
Knee Arthroplasty 2.6%

Drug Data